Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Jump to content

US EditionChange

UK EditionAsia EditionEdición en Español
Sign up to our newslettersSubscribe: $6 for 6 months
More
Best
Climate
TV

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Glaxo approval

Saturday 19 December 1998 01:02 GMT
Comments

Glaxo approval

GLAXO WELLCOME, the pharmaceutical giant, yesterday won US approval for its anti-Aids drug Ziagen.

The company said that it planned to launch the drug, also known as Abacavir, in January. Analysts have predicted that Ziagen, part of Glaxo's strong anti-Aids drug portfolio, could have sales of up to $840m.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in